Healthcare -
Biotechnology - NASDAQ - US
$ 1.09
-0.909 %
$ 227 M
Market Cap
-1.54
P/E
SGMO - LONG-TERM DEBT
Long-term Debt SGMO - Sangamo Therapeutics, Inc.
33.5 M
LAST VALUE
-12.78%
2 YEAR CAGR
3.89%
5 YEAR CAGR
0.00%
10 YEAR CAGR